Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).
Diabetes mellitus, also called diabetes, is a chronic disease ... Treating type 2 diabetes usually involves lifestyle changes and medications, and sometimes people are told to change their diabetes ...